1-9 of 9
Carolyn S. Grove
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting the Myelodysplasia (MDS) Inflammasome with the Oral Wnt/β-Catenin Pathway Inhibitor, ES-3000 in Combination with Oral Decitabine/Cedazuridine (ASTX727) an Australasian Leukaemia and Lymphoma Group Trial (ALLG MDS05/D1)

Anoop K Enjeti, Suthanthirakannan Ramamoorthy, Devendra Hiwase, Asma Ashraf, Belinda E Butcher, Sushma Kollipara, Carolyn S. Grove, Andrew H Wei, Jake Shortt
Journal: Blood
Blood (2024) 144 (Supplement 1): 4605.1.
https://doi.org/10.1182/blood-2024-202604
Published: 2024
Journal Articles

Updated Results and Longer Follow-up from the AUGMENT-101 Phase 2 Study of Revumenib in All Patients with Relapsed or Refractory (R/R) KMT2Ar Acute Leukemia

Ibrahim Aldoss, Ghayas C. Issa, James S. Blachly, Michael J. Thirman, Gabriel N Mannis, Martha L. Arellano, John F. DiPersio, Elie Traer, C. Michel Zwaan, Neerav Shukla, Branko Cuglievan, Carolyn S. Grove, Matthew Greenwood, Christine M. McMahon, Alexander E. Perl, Richard M. Stone, Cristina Papayannidis, David S. Dickens, Maël Heiblig, Andrius Žučenka, Pau Montesinos, Ioannis Mantzaris, Tibor Kovacsovics, Paul J. Shami, Li Yu, Rebecca G. Bagley, Nicole McNeer, Eytan M. Stein
Journal: Blood
Blood (2024) 144 (Supplement 1): 211.
https://doi.org/10.1182/blood-2024-194384
Published: 2024
Journal Articles

Initial Results from a Phase 1/2 Study Evaluating Divesiran, a Novel Galnac Conjugated siRNA, in Patients with Polycythemia Vera (SANRECO)

Marina Kremyanskaya, Ronald Hoffman, Lee Ping Chew, Azizan Sharif, Boyan Semov, Ahlam Naila Kori, Hanlon Sia, Carolyn S. Grove, Ashley P Ng, Akash Kalro, Indu Raman, Ganesh Kasinathan, Olubunmi Oduwole, Monica Gomez-Palou, Henry Fok, Steve Romano, Curtis Rambaran, Alberto Martinez
Journal: Blood
Blood (2024) 144 (Supplement 1): 656.
https://doi.org/10.1182/blood-2024-205854
Published: 2024
Journal Articles

Update of the Ascend-CML Study of Frontline Asciminib: High Rate of Optimal Response and Resistance Due to Mutations Is Rare

David T Yeung, Naranie Shanmuganathan, Agnes S. M. Yong, Jake Shortt, Lynette C.Y. Chee, Nicholas Vialla, Ilona Cunningham, David M Ross, Alwyn D'Souza, Matthew P.F. Wright, Rosemary Harrup, Cecily Forsyth, Robin Filshie, Steven W Lane, Peter J. Browett, Carolyn S. Grove, Mannu Walia, Susan Branford, John Reynolds, Andrew P Grigg, Timothy P Hughes
Journal: Blood
Blood (2024) 144 (Supplement 1): 476.
https://doi.org/10.1182/blood-2024-201218
Published: 2024
Journal Articles

Revumenib As Pre-Emptive Therapy for Measurable Residual Disease in NPM1 mutated or KMT2A- rearranged Acute Myeloid Leukemia: A Domain of the Multi-Arm ALLG AMLM26 Intercept Platform Trial

Sun Loo, Harry Iland, Ing Soo Tiong, David Westerman, Jad Othman, Paula Marlton, Chong Chyn Chua, Duncan Purtill, Hannah Rose, Shaun Fleming, Deepak Singhal, Anoop K Enjeti, William S. Stevenson, Teng Fong Ng, McCulloch Derek, Lachlin Vaughan, Robin Gasiorowski, Adam Ivey, Amanda Souza, Revati Pattani, Natasha S. Anstee, Rachel Koldej, David S. Ritchie, Sanam Loghavi, Naval Daver, Courtney D. DiNardo, Andrew W. Roberts, Carolyn S. Grove, John Reynolds, Andrew H Wei
Journal: Blood
Blood (2024) 144 (Supplement 1): 223.
https://doi.org/10.1182/blood-2024-202895
Published: 2024
Journal Articles

A Phase II Randomized Trial Comparing Low-Dose Cytarabine and Venetoclax +/- Midostaurin in Non-Adverse Cytogenetic Risk Acute Myeloid Leukemia: The ALLG AMLM25 Intervene Trial

Chong Chyn Chua, Blake Hsu, Anoop K Enjeti, Ashish Bajel, Paula Marlton, Shaun Fleming, Devendra Hiwase, Chun Kei Kris Ma, Peter J. Browett, Travis Perera, Carolyn S. Grove, Shuhying Tan, Jad Othman, Julian Cooney, Hannah Rose, Edward S Morris, Rachel Koldej, David S. Ritchie, Kate Mason, Natasha S. Anstee, John Reynolds, Andrew H Wei
Journal: Blood
Blood (2024) 144 (Supplement 1): 217.
https://doi.org/10.1182/blood-2024-199882
Published: 2024
Journal Articles

Dnmt3a Mutation Promotes Expansion of a Quiescent Myeloid Progenitor Population in Npm1 c -Flt3 ITD Acute Myeloid Leukemia

Paniz Tavakoli, Megan Bywater, Jasmin Straube, Victoria Ling, Emily Cooper, Rohit Haldar, Yashaswini Janardhanan, Leanne Cooper, Claudia Bruedigam, Carolyn S. Grove, Steven W Lane
Journal: Blood
Blood (2024) 144 (Supplement 1): 1347.
https://doi.org/10.1182/blood-2024-201250
Published: 2024
Journal Articles

Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1 -mutant acute myeloid leukemia

Oliver M. Dovey, Jonathan L. Cooper, Annalisa Mupo, Carolyn S. Grove, Claire Lynn, Nathalie Conte, Robert M. Andrews, Suruchi Pacharne, Konstantinos Tzelepis, M. S. Vijayabaskar, Paul Green, Roland Rad, Mark Arends, Penny Wright, Kosuke Yusa, Allan Bradley, Ignacio Varela, George S. Vassiliou
Journal: Blood
Blood (2017) 130 (17): 1911–1922.
https://doi.org/10.1182/blood-2017-01-760595
Published: 2017
Includes: Supplemental data
Journal Articles

The FLT3 Inhibitor Quizartinib Provides a Novel Strategy to Inhibit Chemotherapy-Induced Myelosuppression

Wallace Y Langdon, PhD, Samuel J Taylor, PhD, Johanna M Duyvestyn, BSc(Hons), Samantha A Dagger, BSc(Hons), George S. Vassiliou, MD PhD, Carolyn s. Grove, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4041.
https://doi.org/10.1182/blood.V128.22.4041.4041
Published: 2016